A total of 22,064 passengers have so far undergone PCR tests based on a plan launched on March 10 to rapidly identify suspected cases of coronavirus and prevent the spread of new variants.
The second and third phases of clinical studies of the Iranian-Australian Spicogen vaccine for coronavirus will be performed in Iran, Iranian Food and Drug Administration spokesman Kianoush Jahanpour said.
Health Minister Saeed Namaki announced that immunization against coronavirus by the domestic vaccine (COVIRAN BAREKAT) will start by the next week, ISNA reported on Monday.
Soberana-02 COVID-19 vaccine jointly developed by Iran and Cuba will complete clinical trials by mid-June by being administered to 24,000 Iranians.
Considering fake negative COVID-19 test certificates of Iraqi passengers, Health Minister Saeed Namaki emphasized the need for retesting all the passengers at land, sea, and air borders.
The first coronavirus vaccine made by the private sector in Iran succeeded in receiving the code of ethics and entered the phase of clinical studies.
Some 70,000 patients of rare diseases have received the COVID-19 vaccine so far, Mehdi Shadnoush, head of the transplant management and treatment center of the Ministry of Health, has said.
A double dose of COVID-19 vaccines is almost as effective against the fast-spreading variant of the coronavirus first identified in India as it is against Britain’s dominant strain, English health officials said on Saturday.
In a press briefing on Saturday, Alireza Raeisi, spokesman for the National Headquarters for Coronavirus Control (NHCC), laid out safety protocols for the June 18 presidential elections.
Iran has received the second batch of the COVID-19 vaccine from the COVAX facility on Sunday.